Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ)
CNY 6.5
(-0.31%)
CNY 6.5
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.27 Billion | 4 Billion | 3.5 Billion | 3.32 Billion | 3.23 Billion | 3.01 Billion |
| Cost of Revenue | 3.18 Billion | 2.87 Billion | 2.44 Billion | 2.16 Billion | 2 Billion | 1.83 Billion |
| Gross Profit | 1.09 Billion | 1.13 Billion | 1.05 Billion | 1.15 Billion | 1.23 Billion | 1.17 Billion |
| Operating Expenses | 885.89 Million | 897.88 Million | 863.7 Million | 990.29 Million | 1.07 Billion | 1.03 Billion |
| Selling, General and Administrative Expenses | 728.1 Million | 714.74 Million | 689.9 Million | 815.84 Million | 903.99 Million | 838.63 Million |
| Research and Development Expenses | 80.66 Million | 65.46 Million | 70.05 Million | 75.46 Million | 77.96 Million | 72.88 Million |
| Other Expenses | - | 117.66 Million | 103.73 Million | 98.98 Million | 96.25 Million | 549.3 Thousand |
| Cost and Expenses | 4.06 Billion | 3.77 Billion | 3.31 Billion | 3.16 Billion | 3.08 Billion | 2.87 Billion |
| Operating Income | 213.25 Million | 202.09 Million | 146.02 Million | 185.86 Million | 124.1 Million | 92.54 Million |
| Interest Expense | 33.89 Million | 32.86 Million | 38.59 Million | 39.46 Million | 37.07 Million | 31.02 Million |
| Income Tax Expense | 57.59 Million | 51.35 Million | 40.26 Million | 36.01 Million | 39.33 Million | 32.38 Million |
| Earnings before Tax | 214.89 Million | 202.29 Million | 149.73 Million | 138.11 Million | 119.94 Million | 93.09 Million |
| Net Income | 159.28 Million | 154.42 Million | 122.98 Million | 103.72 Million | 80.92 Million | 60.92 Million |
| Earnings Per Share Basic | 0.34 | 0.49 | 0.39 | 0.33 | 0.26 | 0.20 |
| Earnings Per Share Diluted | 0.34 | 0.49 | 0.39 | 0.33 | 0.26 | 0.19 |
| Weighted Average Shares Outstanding | 464.97 Million | 317.16 Million | 312.14 Million | 312.14 Million | 312.14 Million | 312.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 464.97 Million | 317.16 Million | 312.14 Million | 312.14 Million | 312.14 Million | 317.15 Million |
| Gross Margin | 0.26 | 0.28 | 0.30 | 0.35 | 0.38 | 0.39 |
| EBIT Margin | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 |
| EBITDA | 388.66 Million | 371.21 Million | 328.08 Million | 270.67 Million | 243.09 Million | 209.62 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.04 | 0.06 | 0.04 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 953.54 Million | 1.18 Billion | 1.12 Billion | 1.05 Billion | 4.27 Billion | 938.65 Million |
| Cost of Revenue | 756.93 Million | 936.29 Million | 832.63 Million | 799.74 Million | 3.17 Billion | 710.31 Million |
| Gross Profit | 196.61 Million | 250.91 Million | 288.03 Million | 251.61 Million | 1.09 Billion | 228.33 Million |
| Operating Expenses | 154.08 Million | 169.01 Million | 200.74 Million | 222.97 Million | 857.06 Million | 174.59 Million |
| Selling, General and Administrative Expenses | 289.64 Million | 102.89 Million | 197.34 Million | 43.44 Million | - | 226.98 Million |
| Research and Development Expenses | 14 Million | 13.37 Million | 12.98 Million | 21.57 Million | - | 14.06 Million |
| Other Expenses | -149.55 Million | 621.41 Thousand | 203.38 Thousand | 553.29 Thousand | 1.63 Million | 444.11 Thousand |
| Cost and Expenses | 911.01 Million | 1.1 Billion | 1.03 Billion | 1.02 Billion | 4.03 Billion | 884.91 Million |
| Operating Income | 48.47 Million | 68.14 Million | 66.58 Million | 24.33 Million | 213.25 Million | 46.01 Million |
| Interest Expense | 8.02 Million | 8.08 Million | 6.92 Million | 8.34 Million | 33.89 Million | 7.89 Million |
| Income Tax Expense | 4.02 Million | 16.34 Million | 20.42 Million | 8.92 Million | 57.59 Million | 7.41 Million |
| Earnings before Tax | 50.33 Million | 68.76 Million | 66.78 Million | 24.88 Million | 214.89 Million | 46.46 Million |
| Net Income | 47.09 Million | 53.2 Million | 47.01 Million | 16.82 Million | 159.28 Million | 39.44 Million |
| Earnings Per Share Basic | 0.10 | 0.11 | 0.14 | 0.05 | - | 0.12 |
| Earnings Per Share Diluted | 0.10 | 0.11 | 0.14 | 0.05 | - | 0.12 |
| Weighted Average Shares Outstanding | 464.83 Million | 464.83 Million | 331.99 Million | 332.23 Million | 332.12 Million | 332.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 464.83 Million | 464.83 Million | 331.99 Million | 332.23 Million | 332.12 Million | 332.11 Million |
| Gross Margin | 0.21 | 0.21 | 0.26 | 0.24 | 0.26 | 0.24 |
| EBIT Margin | 0.06 | 0.07 | 0.08 | 0.03 | - | 0.07 |
| Profit Margin | 0.05 | 0.04 | 0.04 | 0.02 | 0.04 | 0.04 |
| EBITDA | 58.35 Million | 86.88 Million | 87.83 Million | 32.43 Million | - | 61.41 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.06 | 0.02 | 0.05 | 0.05 |
3294
4544
603219
GH
ALPA
WKGBF